STVN
Stevanato Group SpANYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$4.92B
P/E Ratio
30.53
EPS
$0.59
Beta
0.76
52W High
$28.00
52W Low
$12.89
50-Day MA
$15.82
200-Day MA
$20.13
Dividend Yield
0.00%
Profit Margin
11.70%
Forward P/E
19.46
PEG Ratio
3.57
About Stevanato Group SpA
Stevanato Group SpA (STVN) is a leading global provider of advanced drug delivery systems, specializing in innovative solutions for the pharmaceutical and biotechnology sectors. The company excels in designing and manufacturing high-quality glass and polymer packaging for injectable medications, significantly improving the efficiency and reliability of drug administration. Committed to quality, sustainability, and cutting-edge technology, Stevanato is well-positioned to leverage the growing demand in the biopharmaceutical space, presenting an attractive investment opportunity for institutional investors focused on healthcare innovation and growth.
Fundamentals
| Revenue (TTM) | $1.20B |
| Gross Profit (TTM) | $351.58M |
| EBITDA | $288.58M |
| Operating Margin | 14.20% |
| Return on Equity | 9.59% |
| Return on Assets | 5.27% |
| Revenue/Share (TTM) | $4.41 |
| Book Value | $6.61 |
| Price-to-Book | 2.76 |
| Price-to-Sales (TTM) | 4.09 |
| EV/Revenue | 3.796 |
| EV/EBITDA | 15.64 |
| Quarterly Earnings Growth (YoY) | 2.90% |
| Quarterly Revenue Growth (YoY) | 6.60% |
| Shares Outstanding | $49.71M |
| Float | $48.95M |
| % Insiders | 1.58% |
| % Institutions | 95.81% |
Historical Volatility
HV 10-Day
23.60%
HV 20-Day
37.02%
HV 30-Day
39.69%
HV 60-Day
55.22%
HV Rank
17.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($24.83 target)
2
Strong Buy6
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026